News

Allergan plc announced the U.S. Food and Drug Administration has granted Fast Track designation for AGN-241751, an investigational new treatment for Major Depressive Disorder (MDD).…
Read More...

Immunomedics announced a clinical collaboration with AstraZeneca and its global biologics research and development arm, MedImmune, to evaluate the safety and efficacy of the combination…
Read More...

Adamis Pharmaceuticals Corporation announced that it has been conducting pre-IND development work for a fast-dissolving sublingual tablet containing tadalafil. Adamis intends to submit…
Read More...

Cambrex Corporation announced it has entered into a definitive agreement to acquire Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO),…
Read More...

Koutif Therapeutics announced that KT-1002, which has been selected as its lead compound, has reached clinical candidate status for the treatment of inflammatory bowel disease,…
Read More...

Kite, a Gilead Company and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors (TCRs),…
Read More...

MorphoSys AG and Galapagos NV announced that they have entered into a worldwide, exclusive agreement with Novartis Pharma AG covering the development and commercialization of their…
Read More...

The Hong Kong Polytechnic University (PolyU) will join forces with Axis Therapeutics, a newly established joint venture by two global biopharmaceutical companies - Athenex, Inc. and…
Read More...

About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The invariably fatal disease kills the nerve cells that…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved SYMTUZA, the first and only complete,…
Read More...

Sanofi and REVOLUTION Medicines announced an exclusive worldwide partnership to develop and commercialize targeted therapies, based on the biology of the cellular enzyme SHP2, for…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) as…
Read More...

Asceneuron SA announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to ASN120290 for the treatment of progressive supranuclear palsy (PSP), a…
Read More...

Innovest Global Inc. launched its anticipated Biotechnology & Health Services Division with the acquisition of a twenty percent interest in StemVax Therapeutics, a Translational…
Read More...

Taconic Biosciences and Cyagen Biosciences announced a strategic partnership. Under the agreement terms, the two companies will combine resources to provide the global scientific…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc. provided an overview of their TAK-935/OV935 broad clinical development program. The companies plan to initiate three…
Read More...

Sterigenics announced that it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to…
Read More...

Advanced Proteome Therapeutics Corporation announced the collaboration of APC with Noria Pharmaceuticals Inc. in the rapidly growing field of antibody radioisotope conjugates. APC…
Read More...

AbbVie announced patent license agreements with Mylan over its proposed biosimilar adalimumab product. Under the terms of the agreements, AbbVie will grant Mylan a non-exclusive license…
Read More...

Sinovant Sciences and Renexxion announced the initiation of a collaboration to pursue the development of naronapride, an investigational gastrointestinal prokinetic, in Greater China.…
Read More...